Search

Anna Pagonakis

Examiner (ID: 6985)

Most Active Art Unit
1628
Art Unit(s)
1614, 4173, 1609, 1628, OPET
Total Applications
1238
Issued Applications
444
Pending Applications
73
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9530256 [patent_doc_number] => 08754128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Dioxoanthracene sulphonate derivatives' [patent_app_type] => utility [patent_app_number] => 12/743212 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 3787 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743212 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/743212
Dioxoanthracene sulphonate derivatives Nov 13, 2008 Issued
Array ( [id] => 8435599 [patent_doc_number] => 08283367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Proteasome inhibitors and methods of using the same' [patent_app_type] => utility [patent_app_number] => 12/265998 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42884 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12265998 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/265998
Proteasome inhibitors and methods of using the same Nov 5, 2008 Issued
Array ( [id] => 6292237 [patent_doc_number] => 20100239523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'TLR MODULATORS AND METHODS FOR USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/740690 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9371 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239523.pdf [firstpage_image] =>[orig_patent_app_number] => 12740690 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/740690
TLR MODULATORS AND METHODS FOR USING THE SAME Oct 29, 2008 Abandoned
Array ( [id] => 6275912 [patent_doc_number] => 20100256148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER' [patent_app_type] => utility [patent_app_number] => 12/741118 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 55126 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256148.pdf [firstpage_image] =>[orig_patent_app_number] => 12741118 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/741118
USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER Oct 28, 2008 Abandoned
Array ( [id] => 6517023 [patent_doc_number] => 20100261689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PYRROLO [1,2-C] IMIDAZOLE DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER THERAPIES' [patent_app_type] => utility [patent_app_number] => 12/740677 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12462 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261689.pdf [firstpage_image] =>[orig_patent_app_number] => 12740677 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/740677
PYRROLO [1,2-C] IMIDAZOLE DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER THERAPIES Oct 27, 2008 Abandoned
Array ( [id] => 5331302 [patent_doc_number] => 20090111779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS' [patent_app_type] => utility [patent_app_number] => 12/257854 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11980 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12257854 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/257854
Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis Oct 23, 2008 Issued
Array ( [id] => 6617505 [patent_doc_number] => 20100099775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'METHOD FOR AMELIORATING OF POST-ANESTHETIC RECOVERY' [patent_app_type] => utility [patent_app_number] => 12/253667 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2165 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099775.pdf [firstpage_image] =>[orig_patent_app_number] => 12253667 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/253667
METHOD FOR AMELIORATING OF POST-ANESTHETIC RECOVERY Oct 16, 2008 Abandoned
Array ( [id] => 6508738 [patent_doc_number] => 20100210650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/680657 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4947 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210650.pdf [firstpage_image] =>[orig_patent_app_number] => 12680657 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/680657
ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER Oct 9, 2008 Abandoned
Array ( [id] => 6267687 [patent_doc_number] => 20100298398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'THROMBOPOIETIN RECEPTOR AGONIST (TPORA) KILLS ACUTE HUMAN MYELOID LEUKEMIA CELLS' [patent_app_type] => utility [patent_app_number] => 12/682114 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8967 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298398.pdf [firstpage_image] =>[orig_patent_app_number] => 12682114 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/682114
Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells Oct 7, 2008 Issued
Array ( [id] => 5441909 [patent_doc_number] => 20090093548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'COLCHINE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/246034 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24208 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093548.pdf [firstpage_image] =>[orig_patent_app_number] => 12246034 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/246034
COLCHINE COMPOSITIONS AND METHODS Oct 5, 2008 Abandoned
Array ( [id] => 6603272 [patent_doc_number] => 20100323033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'CANCER SENSITIZER COMPRISING CHLOROGENIC ACID' [patent_app_type] => utility [patent_app_number] => 12/740978 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2507 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323033.pdf [firstpage_image] =>[orig_patent_app_number] => 12740978 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/740978
CANCER SENSITIZER COMPRISING CHLOROGENIC ACID Sep 30, 2008 Abandoned
Array ( [id] => 6631183 [patent_doc_number] => 20100311765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'METABOLIC DEGRADATION INHIBITORS FOR ANTI-HYPERPROLIFERATIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/679795 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4648 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311765.pdf [firstpage_image] =>[orig_patent_app_number] => 12679795 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/679795
METABOLIC DEGRADATION INHIBITORS FOR ANTI-HYPERPROLIFERATIVE AGENTS Sep 25, 2008 Abandoned
Array ( [id] => 5441872 [patent_doc_number] => 20090093511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Mast cell stabilizers in the treatment of obesity' [patent_app_type] => utility [patent_app_number] => 12/232789 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6476 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093511.pdf [firstpage_image] =>[orig_patent_app_number] => 12232789 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/232789
Mast cell stabilizers in the treatment of obesity Sep 23, 2008 Issued
Array ( [id] => 7733419 [patent_doc_number] => 20120015919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/132893 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21842 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015919.pdf [firstpage_image] =>[orig_patent_app_number] => 13132893 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/132893
THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS Sep 22, 2008 Abandoned
Array ( [id] => 6262568 [patent_doc_number] => 20100297113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/679828 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 43906 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297113.pdf [firstpage_image] =>[orig_patent_app_number] => 12679828 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/679828
Quinone derivatives, pharmaceutical compositions, and uses thereof Sep 21, 2008 Issued
Array ( [id] => 5404536 [patent_doc_number] => 20090239850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Kinase protein binding inhibitors' [patent_app_type] => utility [patent_app_number] => 12/283826 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 38294 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239850.pdf [firstpage_image] =>[orig_patent_app_number] => 12283826 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/283826
Kinase modulating compounds and uses thereof for treatment of cancer Sep 14, 2008 Issued
Array ( [id] => 5272216 [patent_doc_number] => 20090075992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Pteridine Derivatives as Nitric Oxide Synthase Activators' [patent_app_type] => utility [patent_app_number] => 12/207631 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7147 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075992.pdf [firstpage_image] =>[orig_patent_app_number] => 12207631 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/207631
Pteridine Derivatives as Nitric Oxide Synthase Activators Sep 9, 2008 Abandoned
Array ( [id] => 6002941 [patent_doc_number] => 20110118222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'PSEUDOLIPID COMPLEX MIXTURE AND A SKIN EXTERNAL APPLICATION COMPOSITION CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 13/003519 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3536 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118222.pdf [firstpage_image] =>[orig_patent_app_number] => 13003519 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/003519
Pseudolipid complex mixture and a skin external application composition containing same Sep 1, 2008 Issued
Array ( [id] => 5338043 [patent_doc_number] => 20090054507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'CONTROL OF MALIGNANT CELLS BY KINASE INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/201693 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 17799 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054507.pdf [firstpage_image] =>[orig_patent_app_number] => 12201693 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/201693
CONTROL OF MALIGNANT CELLS BY KINASE INHIBITION Aug 28, 2008 Abandoned
Array ( [id] => 5453387 [patent_doc_number] => 20090069424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'TGF-alpha expression inhibitors' [patent_app_type] => utility [patent_app_number] => 12/230137 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4031 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069424.pdf [firstpage_image] =>[orig_patent_app_number] => 12230137 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/230137
TGF-alpha expression inhibitors Aug 24, 2008 Abandoned
Menu